Long‐term follow‐up, quality of life, and survival of patients with Lambert‐Eaton myasthenic syndrome
Citation Manager Formats
Make Comment
See Comments
This article has a correction. Please see:

Article Information
- Received April 28, 2019
- Accepted in final form July 22, 2019
- First Published December 12, 2019.
Article Versions
- Previous version (December 12, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Alexander F. Lipka, MD,
- Marion I. Boldingh, MD, PhD,
- Erik W. van Zwet, PhD,
- Marco W.J. Schreurs, PhD,
- Jan B.M. Kuks, MD, PhD,
- Chantal M. Tallaksen, MD, PhD,
- Maarten J. Titulaer, MD, PhD and
- Jan J.G.M. Verschuuren, MD, PhD
- Alexander F. Lipka, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marion I. Boldingh, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
FP7 frame programme FIGHT MG 242210 2010-2015 Foreningen for muskelsyke 2010-2015
NONE
NONE
NONE
NONE
NONE
NONE
- Erik W. van Zwet, PhD,
NONE
NONE
NONE
Statistica Neerlandica co-editor 2015-2017
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marco W.J. Schreurs, PhD,
NONE
NONE
(1) Thermo Scientific, funding for travel to conference(2) Inova, funding for travel to conference
(1) Nederlands tijdschrift voor Allergie & Astma, editorial advisory board member, 2015-
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Combined ophthalmic research, Rotterdam(2) Stichting de Merel, Den Haag(3) Stichting Blindenbelangen, Rotterdam(4) Stichting Lijf en Leven
NONE
NONE
NONE
NONE
NONE
NONE
- Jan B.M. Kuks, MD, PhD,
NONE
NONE
NONE
Name: NERVUS (Dutch CME Journal Neurology)Editor in Chief Since 2016
NONE
Textbook of clinical NeurologySpringer The Netherlands2018Leerboek klinische neurologieSpringer The NetherlandsFrom 2003
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Chantal M. Tallaksen, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Maarten J. Titulaer, MD, PhD and
NONE
NONE
NONE
(1) Neurology: Neuroimmunology & Neuroinflammation, since June 2014
(1) filed a patent for
NONE
NONE
NONE
NONE
NONE
NONE
(1) Medimmune LLC, research funds for serving on the scientific advisory board; (2) Guidepoint Global LLC, research funds for consultancy; (3) Novartis, research funds for teaching; (4) unrestricted research grant from Euroimmun AG.
(1) supported by the Netherlands Organisation for Scientific Research (NWO, Veni incentive and Memorabel initiative)
(1) Previously supported by an ErasmusMC fellowship
(1) supported by the Dutch Epilepsy Foundations, projectnumbers 14-19 and 19-08.
NONE
NONE
NONE
NONE
NONE
NONE
- Jan J.G.M. Verschuuren, MD, PhD
Myasthenia Foundation of America (MGFA) medical/scientific advisory board. Study Steering Committee of Argenx. Advisory meeting for Rapharma. All reimbursements were received by the LUMC.
NONE
NONE
Journal of Neuromuscular Diseases, member editorial board, 2014-now
Patents on MuSK myasthenia gravis
NONE
NONE
The Neurology department of the LUMC has received fees from Alexion, Argen-X, and Rapharma because of consultancies
NONE
NONE
NONE
The LUMC received support from Argenx for research on autoimmune myasthenia gravis
NONE
NONE
Princes Beatrix Spierfonds, grant for MG research, Prinicpal investigator.
NONE
NONE
The LUMC received royalties for a diagnostic antibody test from TECAN/IBL.
NONE
NONE
NONE
- From the Departments of Neurology (A.F.L., J.J.G.M.V.) and Biostatistics (E.W.v.Z.), Leiden University Medical Center; Department of Neurology (A.F.L.), Groene Hart Hospital, Gouda, the Netherlands; Department of Neurology (M.I.B., C.M.T.), Oslo University Hospital, Norway; Departments of Immunology (M.W.J.S.) and Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam; Department of Neurology (J.B.M.K.), University Medical Center Groningen, the Netherlands; and Faculty of Medicine (C.M.T.), University of Oslo, Norway.
- Correspondence
Dr. Lipka a.f.lipka{at}lumc.nl
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan